{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:10:20Z","timestamp":1790424620018,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.lfs.2021.119655","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T16:15:08Z","timestamp":1621872908000},"page":"119655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Effect of Baricitinib on TPA-induced psoriasis like skin inflammation"],"prefix":"10.1016","volume":"279","author":[{"given":"Deepak","family":"Hiraganahalli Bhaskarmurthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Evan Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2021.119655_bb0005","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1093\/hmg\/ddh094","article-title":"The genetics of psoriasis, psoriatic arthritis and atopic dermatitis","volume":"13","author":"Bowcock","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.lfs.2021.119655_bb0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team, global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2021.119655_bb0020","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.1000148","article-title":"Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model","volume":"186","author":"Nakajima","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2021.119655_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 family of cytokines in psoriasis: IL-17A and beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2021.119655_bb0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.lfs.2021.119655_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.119655_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9440(10)65109-7","article-title":"Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis","volume":"155","author":"Nickoloff","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2021.119655_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.sder.2010.03.001","article-title":"New insights in the immunologic basis of psoriasis","volume":"29","author":"Nograles","year":"2010","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.lfs.2021.119655_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02342","article-title":"Targeting the Janus kinase family in autoimmune skin diseases","volume":"10","author":"Howell","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2021.119655_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7897263","article-title":"Selective immunomodulation of inflammatory pathways in keratinocytes by the Janus kinase (JAK) inhibitor tofacitinib: implications for the employment of JAK-targeting drugs in psoriasis","volume":"2018","author":"Morelli","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.lfs.2021.119655_bb0060","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","article-title":"Janus kinase inhibitors in dermatology: a systematic review","volume":"76","author":"Shreberk-Hassidim","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3899\/jrheum.171361","article-title":"Safety profile of baricitinib in patients with active rheumatoid arthritis with over 2 years median time in treatment","volume":"46","author":"Smolen","year":"2019","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0070","author":"PubChem"},{"key":"10.1016\/j.lfs.2021.119655_bb0075","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/intimm\/dxn068","article-title":"TPA induction leads to a Th17-like response in transgenic K14\/VEGF mice: a novel in vivo screening model of psoriasis","volume":"20","author":"Hvid","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.lfs.2021.119655_bb0080","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.4049\/jimmunol.1400692","article-title":"Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-\u03b3-mediated skin inflammation","volume":"193","author":"Hsieh","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2021.119655_bb0085","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jid.2015.12.021","article-title":"p53 is a direct transcriptional repressor of keratin 17: lessons from a rat model of radiation dermatitis","volume":"136","author":"Liao","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0090","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/bjd.14403","article-title":"A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1\/JAK2 inhibitor, in patients with moderate-to-severe psoriasis","volume":"174","author":"Papp","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0095","first-page":"1","article-title":"Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture","volume":"48","author":"Blumberg","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2021.119655_bb0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.intimp.2015.02.007","article-title":"Curcumin relieves TPA-induced Th1 inflammation in K14-VEGF transgenic mice","volume":"25","author":"Sun","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2021.119655_bb0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.jid.5701061","article-title":"Topical N-acetyl-S-farnesyl-L-cysteine inhibits mouse skin inflammation, and unlike dexamethasone, its effects are restricted to the application site","volume":"128","author":"Gordon","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1083\/jcb.120.1.217","article-title":"Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C","volume":"120","author":"Dlugosz","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119655_bb0115","doi-asserted-by":"crossref","first-page":"17758","DOI":"10.4238\/2015.December.21.49","article-title":"Research note mesenchymal stem cells from skin lesions of psoriasis patients promote proliferation and inhibit apoptosis of HaCaT cells","volume":"14","author":"Liu","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.lfs.2021.119655_bb0120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4103\/ijdvl.IJDVL_741_18","article-title":"Aberrant expression of bradykinin b2 receptor in the epidermis of patients with psoriasis vulgaris","volume":"85","author":"Liu","year":"2019","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.lfs.2021.119655_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.22159\/ijap.2019v11i2.31338","article-title":"Recent advances and future prospects of non-invasive insulin delivery systems","author":"Al-Tabakha","year":"2019","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.lfs.2021.119655_bb0130","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1080\/13880209.2016.1194865","article-title":"Citrus hallabong [(Citrus unshiu \u00d7 C. sinensis) \u00d7 C. reticulata] exerts potent anti-inflammatory properties in murine splenocytes and TPA-induced murine ear oedema model","volume":"54","author":"Herath","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.lfs.2021.119655_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4103\/ijdvl.IJDVL_298_18","article-title":"PLA2R antibody positive membranous glomerulonephropathy associated with psoriasis vulgaris","volume":"85","author":"Arora","year":"2019","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.lfs.2021.119655_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The emerging role of interleukin-17 in the pathogenesis of psoriasis: preclinical and clinical findings","volume":"133","author":"Martin","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/1523-1747.ep12582813","article-title":"Stratum corneum structure and function correlates with phenotype in psoriasis","volume":"107","author":"Ghadially","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archderm.1994.01690040056007","article-title":"Abnormality of water barrier function in psoriasis: role of ceramide fractions","volume":"130","author":"Motta","year":"1994","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.lfs.2021.119655_bb0155","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.4049\/jimmunol.165.7.4076","article-title":"Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells","volume":"165","author":"Bonish","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2021.119655_bb0160","doi-asserted-by":"crossref","first-page":"e980419","DOI":"10.1155\/2013\/980419","article-title":"Promising new treatments for psoriasis","volume":"2013","author":"Dubois Declercq","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.lfs.2021.119655_bb0165","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/2229-5178.193915","article-title":"Biologics use in Indian psoriasis patients","volume":"7","author":"Rajagopalan","year":"2016","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.lfs.2021.119655_bb0170","first-page":"304","article-title":"Tofacitinib and other kinase inhibitors in the treatment of psoriasis","volume":"104","author":"Ortiz-Ib\u00e1\u00f1ez","year":"2013","journal-title":"ActasDermosifiliogr"},{"key":"10.1016\/j.lfs.2021.119655_bb0175","article-title":"Transdermal and topical drug administration in the treatment of pain","volume":"23","author":"Leppert","year":"2018","journal-title":"Mol. Basel Switz."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052100641X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052100641X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:40:25Z","timestamp":1731591625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052100641X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":35,"alternative-id":["S002432052100641X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119655","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Baricitinib on TPA-induced psoriasis like skin inflammation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119655"}}